134 related articles for article (PubMed ID: 32472749)
1. Adherence of head and neck squamous cell carcinoma patients to tumor board recommendations.
Rangabashyam MS; Lee SY; Tan SY; Mueller S; Sultana R; Ho J; Skanthakumar T; Tan NC; Tan HK; Soo KC; Iyer NG
Cancer Med; 2020 Jul; 9(14):5124-5133. PubMed ID: 32472749
[TBL] [Abstract][Full Text] [Related]
2. The impact of the multidisciplinary tumor board on head and neck cancer outcomes.
Liu JC; Kaplon A; Blackman E; Miyamoto C; Savior D; Ragin C
Laryngoscope; 2020 Apr; 130(4):946-950. PubMed ID: 31095740
[TBL] [Abstract][Full Text] [Related]
3. Association of Nonsteroidal Anti-inflammatory Drug Use With Survival in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Chemoradiation Therapy.
Iovoli AJ; Hermann GM; Ma SJ; Platek AJ; Farrugia MK; Yau E; Wooten KE; Arshad H; Gupta V; Kuriakose MA; Hicks WL; Singh AK
JAMA Netw Open; 2020 Jun; 3(6):e207199. PubMed ID: 32602907
[TBL] [Abstract][Full Text] [Related]
4. Adherence to Multidisciplinary Tumor Board Recommendations in Patients With Curable Esophageal and Gastric Cancers.
Soon JJY; Zhao Y; Shannon NB; Tan JTH
J Gastrointest Cancer; 2023 Jun; 54(2):614-622. PubMed ID: 35759206
[TBL] [Abstract][Full Text] [Related]
5. Patient Choice of Nonsurgical Treatment Contributes to Disparities in Head and Neck Squamous Cell Carcinoma.
Parhar HS; Anderson DW; Janjua AS; Durham JS; Prisman E
Otolaryngol Head Neck Surg; 2018 Jun; 158(6):1057-1064. PubMed ID: 29436282
[TBL] [Abstract][Full Text] [Related]
6. Head and neck squamous cell carcinoma of unknown primary: Outcomes of a pre-defined institutional treatment policy in a region with a high prevalence of skin cancer.
Huo M; Panizza B; Bernard A; Porceddu SV
Oral Oncol; 2018 Feb; 77():43-48. PubMed ID: 29362125
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival in patients with metastatic head and neck squamous cell carcinoma treated with metastasis-directed therapy.
Beckham TH; Leeman JE; Xie P; Li X; Goldman DA; Zhang Z; Sherman E; McBride S; Riaz N; Lee N; Tsai CJ
Br J Cancer; 2019 Nov; 121(11):897-903. PubMed ID: 31649318
[TBL] [Abstract][Full Text] [Related]
8. Success of salvage treatment: a critical appraisal of salvage rates for different subsites of HNSCC.
Matoscevic K; Graf N; Pezier TF; Huber GF
Otolaryngol Head Neck Surg; 2014 Sep; 151(3):454-61. PubMed ID: 24894422
[TBL] [Abstract][Full Text] [Related]
9. Quality insurance in head and neck cancer multidisciplinary team meetings: A watchful eye on real-life experience.
Guy JB; Benna M; Xia Y; Daguenet E; Ben Mrad M; Jmour O; Vial N; Lelonge Y; Fournel P; Prades JM; Vallard A; Magné N
Oral Oncol; 2019 Apr; 91():35-38. PubMed ID: 30926060
[TBL] [Abstract][Full Text] [Related]
10. Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer.
Graboyes EM; Garrett-Mayer E; Ellis MA; Sharma AK; Wahlquist AE; Lentsch EJ; Nussenbaum B; Day TA
Cancer; 2017 Dec; 123(24):4841-4850. PubMed ID: 28841234
[TBL] [Abstract][Full Text] [Related]
11. Chemoradiation and local recurrence of head and neck squamous cell carcinoma and the risk of carotid artery blowout.
Jacobi C; Gahleitner C; Bier H; Knopf A
Head Neck; 2019 Sep; 41(9):3073-3079. PubMed ID: 31070287
[TBL] [Abstract][Full Text] [Related]
12. Outcomes in N3 Head and Neck Squamous Cell Carcinoma and Role of Upfront Neck Dissection.
Boros A; Blanchard P; Dade A; Gorphe P; Breuskin I; Even C; Nguyen F; Deutsch E; Bidault F; Janot F; Temam S; Mirghani H; Tao Y
Laryngoscope; 2021 Mar; 131(3):E846-E850. PubMed ID: 32833260
[TBL] [Abstract][Full Text] [Related]
13. Upfront PET/CT affects management decisions in patients with recurrent head and neck squamous cell carcinoma.
Rohde M; Nielsen AL; Johansen J; Sørensen JA; Diaz A; Pareek M; Asmussen JT; Gerke O; Thomassen A; Gyldenkerne N; Døssing H; Bjørndal K; Høilund-Carlsen PF; Godballe C
Oral Oncol; 2019 Jul; 94():1-7. PubMed ID: 31178202
[TBL] [Abstract][Full Text] [Related]
14. PET/CT prior to salvage surgery in recurrent head and neck squamous cell carcinoma.
Nøhr A; Gram SB; Charabi B; Tvedskov JF; Wessel I; Friborg J; Håkansson K; von Buchwald C; Fischer BM; Rasmussen JH
Eur Arch Otorhinolaryngol; 2019 Oct; 276(10):2895-2902. PubMed ID: 31297609
[TBL] [Abstract][Full Text] [Related]
15. Treatment Package Time in Node-Positive Cutaneous Head and Neck Squamous Cell Carcinoma.
Daniels CP; Bressel M; Corry J; Cole A; Chua MS; Tiong A; Hirshoren N; Dixon B; McDowell L
Pract Radiat Oncol; 2020; 10(1):29-35. PubMed ID: 31606546
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment High MCV as Adverse Prognostic Marker in Nonanemic Patients with Head and Neck Cancer.
Borsetto D; Polesel J; Tirelli G; Menegaldo A; Baggio V; Gava A; Nankivell P; Pracy P; Fussey J; Boscolo-Rizzo P
Laryngoscope; 2021 Mar; 131(3):E836-E845. PubMed ID: 32589769
[TBL] [Abstract][Full Text] [Related]
17. Influence of comorbidity on therapeutic decision making and impact on outcomes in patients with head and neck squamous cell cancers: Results from a prospective cohort study.
Agarwal J; Adulkar D; Swain M; Chakraborty S; Gupta T; Budrukkar A; Ghosh-Laskar S; Murthy V
Head Neck; 2019 Mar; 41(3):765-773. PubMed ID: 30552822
[TBL] [Abstract][Full Text] [Related]
18. Utility of the Surgical Apgar Score in Head and Neck Squamous Cell Carcinoma.
Prince AC; Day KE; Lin CP; Greene BJ; Carroll WR
Otolaryngol Head Neck Surg; 2018 Sep; 159(3):466-472. PubMed ID: 29870298
[TBL] [Abstract][Full Text] [Related]
19. Sarcomatoid Carcinoma in the Head and Neck: A Population-Based Analysis of Outcome and Survival.
Ding L; Bi ZF; Yuan H; Zhao XH; Guan XD; Yao HR; Liu YM
Laryngoscope; 2021 Feb; 131(2):E489-E499. PubMed ID: 33135805
[TBL] [Abstract][Full Text] [Related]
20. Disease course after the first recurrence of head and neck squamous cell carcinoma following (chemo)radiation.
de Ridder M; de Veij Mestdagh PD; Elbers JBW; Navran A; Zuur CL; Smeele LE; Al-Mamgani A
Eur Arch Otorhinolaryngol; 2020 Jan; 277(1):261-268. PubMed ID: 31602525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
